Evidence map›Paper›PMID 38673764›Full record

ArticleInternational journal of molecular sciences2024

Activation of the RIG-I/MAVS Signaling Pathway during Human Adenovirus Type 3 Infection Impairs the Pro-Inflammatory Response Induced by Secondary Infection with

Jiehan Chen, Qiaowen Wang, Biying Zhong, Huiying Zheng, Dingjun Wang, Xiao Huang, Li Liu, Tiantian Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jiehan ChenSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0000-0001-8802-7061
Qiaowen WangSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0009-0008-4897-2235
Biying ZhongSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Huiying ZhengSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0009-0004-8253-4301
Dingjun WangSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Xiao HuangSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Li LiuSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Tiantian LiuSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Guangdong Pharmaceutical University · CN

Funding

Guangdong key research and development program (2022B1111020003)Guangzhou Municipal Health Commission YWH(2022)3398）National Key Research and Development Entrepreneurship Leadership Project in Guangzhou Development Zone of China (2020-L037)
6 · The paper itself

Abstract

The exacerbation of pneumonia in children with human adenovirus type 3 (HAdV-3E) is secondary to a

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanDEAD Box Protein 58Signal TransductionStaphylococcal InfectionsStaphylococcus aureusA549 CellsAdaptor Proteins, Signal TransducingCoinfectionHost-Pathogen InteractionsHumansInflammationNF-kappa BReceptors, ImmunologicUbiquitin ThiolesteraseAdaptor Proteins, Signal TransducingDEAD Box Protein 58MAVS protein, humanNF-kappa BReceptors, ImmunologicRIGI protein, humanUbiquitin ThiolesteraseUSP18 protein, humanadenovirus type 3coinfectionStaphylococcus aureus

Identifiers

PMID38673764
PMCPMC11049948
OpenAlexW4394691435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.